Intuitive Surgical, Inc. (ISRG)
Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder
Intuitive Surgical continues robust double-digit growth, with Q4 2025 revenues up 19% y/y and strong da Vinci 5 adoption. The firm's 2026 procedure growth guidance of 13–15% disappointed versus expectations, triggering a recent share sell-off despite operational strength. Elevated multiples reflect the company's market dominance, but tactical buying on dips remains warranted for long-term growth investors.
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Intuitive Surgical (ISRG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Get a deeper insight into the potential performance of Intuitive Surgical (ISRG) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Intuitive Surgical, Inc. (ISRG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Intuitive Surgical: An Easy 'Buy And Hold' For Long-Term Outperformance
Intuitive Surgical, Inc. dominates surgical robotics with an 80% global share and a robust, recurring-revenue business model anchored by the da Vinci platform. ISRG's installed base and procedure volumes continue double-digit growth, driven by superior clinical outcomes and high hospital switching costs. Despite premium valuation (forward P/E ~64), ISRG's pristine balance sheet, strong margins, and relentless innovation justify a long-term Buy rating.
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: Here's Why
The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $585.08, representing a -1.21% change from its previous close.
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.
Is ISRG Stock Still A Buy At $600?
ISRG stock has climbed nearly 40% from its October 2025 lows of approximately $425, currently trading near $590. What has spurred this remarkable rise?
Watch 5 AI-Powered Medical Stocks for a Strong Portfolio in 2026
LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.
ISRG Sees 91% SP Growth: A Turning Point for Single-Port Surgery?
ISRG's single-port platform posts 91% procedure growth, led by Korea, with U.S. momentum building as new tools and indications expand adoption.
Here Are My Top 2 No-Brainer Growth Stocks to Buy Now
These healthcare growth stocks are profitable and revenue is growing at a double-digit pace. Intuitive Surgical is the top global player in the field of robotic surgery.
